Gilead Sciences, Inc. ( NASDAQ: GILD) Goldman Sachs 46th Annual Global Healthcare Conference June 10, 2025 11:20 AM ET Salveen Jaswal Richter - Goldman Sachs Group, Inc., Research Division ...

Roche executive Daniel O’Day is to take the helm at Gilead after John Milligan steps down as CEO at the end of this year, the company has announced. Currently CEO of Roche Pharmaceuticals since ...

Gilead Sciences has shored up its antibody-drug conjugate pipeline by licensing a candidate from German biotech Tubulis in a deal worth up to $415 million. The agreement includes an upfront ...

Reigning Ojai champion Rishvanth Krishna secures the championship point for the Trojans by rallying to win his singles match against a highly-ranked opponent.

Whyte’s auction of Irish & International art promises to deliver another exciting opportunity for collectors to acquire rare artworks of outstanding quality and enduring value.

(Reuters) -The U.S. Food and Drug Administration has placed a clinical hold on Gilead Sciences' trials testing a combination ...

May 21, 2025 • We asked some of our trusted critics which upcoming books they are most looking forward to. Here are the fiction and nonfiction titles they picked. November 25, 2024 • Books We ...

How it’s possible to score only 1 point in NFL A Division of NBCUniversal. DISCLAIMER: This site and the products offered are for entertainment purposes only, and there is no gambling offered on this ...

President Trump has set his sights on defunding colleges, singling out some of the world’s wealthiest schools in what critics say is an attack on academic freedom. By Alan Blinder The Trump ...

CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), today announced that on June 2, 2025, the Compensation Committee of the company’s Board of Directors granted to ...